Join
Live feed
·
INSIDERFilingvia Quantisnow
Catalyst Pharmaceuticals Inc. logo

Chief Financial Officer Kalb Michael Wayne returned $430,448 worth of shares to the company (13,665 units at $31.50), closing all direct ownership in the company (SEC Form 4) to satisfy withholding obligation

ByQuantisnow·Wall Street's wire, on your screen.
CPRX· Catalyst Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CPRX (Catalyst Pharmaceuticals Inc.) and more on Quantisnow.

Chief Financial Officer Kalb Michael Wayne returned $430,448 worth of shares to the company (13,665 units at $31.50), closing all direct ownership in the company (SEC Form 4) to satisfy withholding obligation | Quantisnow